Vaccine against COVID-19
Covaxin ▸ Facts ▸ Comments ▸ News ▸ Videos
Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News
Credit: Oneindia Duration: 03:37Published
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News
Credit: Oneindia Duration: 01:23Published
You Might Like
Delay in Covaxin's approval, WHO awaits crucial infoUntil Covaxin gets an emergency use authorisation from WHO it cannot get widespread acceptability as a safe and effective vaccine around the world.
Need more info, can’t cut corners on Covaxin: WHOThe WHO said on Monday it was “aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 emergency use listing (EUL)” but that it “cannot cut..
Cannot cut corners, need to thoroughly evaluate product before recommending emergency use: WHO on CovaxinThe WHO on Monday said it cannot cut corners and needs to thoroughly evaluate a product before recommending it for EUL to ensure it is safe and effective. “We are aware that many people are waiting..
WHO's technical advisory group to meet on October 26 on EUL for Covaxin
Covaxin's approval for children aged 2-18 years under experts' opinion, evaluation: SourcesThe final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday. Earlier on Tuesday, official sources had..
India resumes vaccine exports as domestic stocks build up: OfficialsOne million shots of Covaxin produced by Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said. Vaccines have also been sent to Nepal, a government source said, adding that..
Expert panel recommends approving Covaxin for kidsThe final approval of EUA from the drug regulator and inclusion of the vaccine in the national Covid immunisation programme for the paediatric population will take a few more days as data submitted by..
Expert panel approves Covaxin for children between 2-18 years
BIG BREAKING: DGCI approves Covaxin for kids in 2-18 age groupCovaxin approved for kids between 2-18
SII gets nod to send Covid vaccines to Nepal, Bangaldesh, Myanmar, bulk to AstraZeneca; Bharat Biotech to IranThe government has permitted Serum Institute of India (SII) to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, while Bharat Biotech will provide Iran with 10 lakh doses of..
Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO
WHO likely to decide on Covaxin emergency usage by next weekThe approval for the emergency use authorization for Covaxin will most likely be issued by WHO in the next week, as per reports.
WHO nod likely for Covaxin this monthThe World Health Organisation’s approval for emergency use listing (EUL) of Bharat Biotech’s Covaxin is expected to take a few more weeks to arrive. The decision, however, will be taken in October..
WHO to take final call on Covaxin EUL next weekThe World Health Organisation (WHO) will be taking a final call on Bharat Biotech’s Emergency Use Listing (EUL) application for India’s first indigenously developed Covid-19 vaccine Covaxin next..
WHO to give approval to Covaxin this month, say top health experts
Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19The Centre has received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19, according to official documents. Serum..
AIIMS Delhi Director hopes for early approval of Covid-19 vaccine Covaxin by WHO
‘WHO stand on Covaxin a serious setback for India’
Month after month, Covaxin missing production targetHomegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine...
Covaxin yet to receive WHO's emergency use clearance over technical queries: ReportThe countries that have approved Covaxin include Iran, the Philippines, Mauritius, Mexico, Nepal, Guyana, Paraguay, and Zimbabwe.
Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairmanCovaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing..
Covaxin kids trial over, Bharat Biotech to submit data to DCGI next week
Covaxin may soon get WHO approval as expert group scheduled to meet next monthSAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Bharat Biotech awaits feedback from WHO for Covid-19 vaccine Covaxin's emergency use listing
Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK PaulIndia's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients to travel abroad without mandatory..
Centre says two doses of Covaxin must even for Covid-cured peopleA person must take two doses of the anti-Covid vaccine, Covaxin, even after recovering from Covid-19, for being considered as a fully vaccinated individual, a Union health ministry official said on..
Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these stepsIndia is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
First batch of Covaxin rolls out of Gujarat plant of Bharat Biotech
First commercial batch of Covaxin rolls out from Bharat Biotech's Ankleshwar plantIn a move that will augment the supply of indigenously developed Covid-19 vaccine Covaxin, Bharat Biotech on Sunday announced the rollout of the first commercial batch of Covaxin from its Chiron..
1 Covaxin dose to survivor equals 2 doses to uninfectedA single-dose of Bharat Biotech’s Covaxin in people who had been infected with Covid-19 previously generates antibody response similar to that provided by two doses of the vaccine in those without..
ICMR study reveals how single Covaxin jab can be equivalent to two doses for special casesA new study by ICMR has shown how a single Covaxin jab can be equivalent to two doses of the vaccine in previously COVID infected people.
Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMRA single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of Covid infection with two doses of vaccine, says Indian Council of..
Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report
Covid vaccination for kids may start only by March ’22Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
Kerala man files plea in court for Covishield after taking both doses of Covaxin, read whyThe man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin.
IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month
75 million Covaxin doses supplied, more by September, says Bharat Biotech's Suchitra Ella
Union health minister Mansukh Mandaviya meets WHO Chief Scientist Dr Soumya Swaminathan, discusses WHO's approval of CovaxinUnion health minister Mansukh Mandaviya on Thursday met World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan and held a discussion over the world body's approval of Bharat Biotech's..
‘WHO call on emergency nod for Covaxin in September’
WHO decision on Covaxin authorisation likely next month
DCGI gives nod to conduct study on mixing Covaxin, CovishieldThe Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines. The research study will be done by Christian Medical College, Vellore, said..
Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K PaulDCGI has approved a proposal from the CMC Vellore to carry out trials on the mixed use of COVID-19 vaccines, Covishield and Covaxin in people.
Govt approves Bharat Biotech's Ankleshwar plant for manufacturing CovaxinUnion health minister Mansukh Mandaviya on Tuesday said the government has approved Bharat Biotech’s vaccine manufacturing facility at Ankleshwar in Gujarat for manufacturing India’s first..
Covishield-Covaxin mix offers better shield, says ICMR studyThe study examined 18 individuals in UP who inadvertently received Covishield as the first jab and Covaxin as the second. "The findings suggest that immunisation with a combination of an adenovirus..
Mixing and matching of Covaxin and Covishield vaccines show better result: ICMR
136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-DecemberMore than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the..
Bharat Biotech issues clarification on quality concerns with CovaxinThe statement came after reports that test batches of Covaxin were not satisfactory and got rejected leading to delayed production.
Covaxin receives certificate of Good Manufacturing Practice from Hungarian authorities
Covaxin output set to rise; govt hopes to meet 135 crore-dose goalIndian Immunologicals Limited is likely to start supply of an additional 2 million doses of Covaxin from August-September, whereas Bharat Biotech’s Ankleshwar facility is likely to add 6 million..
Covaxin batches rejected due to stability issues caused disruption in July supply